Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

PSNC pulls stock shortages list as reports plummet

Pharmacists are making "very few" notifications of supply problems because shortages have become "routine", says the negotiator

PSNC has discontinued its list of branded medicines shortages because pharmacists are not reporting them.


The list, which PSNC removed from its website last month, did not reflect products that suffered regular supply problems because pharmacists were making "very few" reports, the negotiator said at the time.


PSNC began maintaining a list of branded medicines in short supply in 2008, as a way to highlight to wholesalers which products should not be exported.


Shortages had "sadly become a routine part" of pharmacists' work and were not being sufficiently reported to make the list accurate, PSNC head of support services Komal George told C+D yesterday (May 27).  


Pharmacists are making "very few" notifications of supply problems because shortages have become "routine", says the negotiator

More on stock shortages

Video: No solution to stock shortages

C+D stock shortages report fails to rouse ‘complacent' government

C+D report: Medicines shortages 2013


Contractors can still alert the negotiator to problems obtaining a branded medicine by filling in an online questionnaire, which is passed on to the Department of Health. PSNC also maintains a list of branded medicines that have had their supply affected by manufacturing problems.


Earlier this month, pharmacy minister Earl Howe urged pharmacists to report instances of or potential for patient harm due to shortages, in response to a C+D report that highlighted evidence of harm in three quarters of cases.


Earl Howe ignored C+D's call for "urgent action" to improve the supply chain and said the size of the supply network meant there would "occasionally" be problems with obtaining some medicines.


Contractors branded his response "unacceptable" and said it was time for the government to take its "head out of the sand".


Are you less likely to report supply issues than you were in the past? If so, why?
 
We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD017043

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel